Widespread RFS predominates during early stages, whereas structural atrophy gradually becomes the dominant imaging feature as the disease advances, underscoring the potential of multimodal imaging biomarkers for the early diagnosis of IPD.
Abstract
Background The underlying mechanisms linking structural and metabolic alterations of idiopathic Parkinson’s disease (IPD) remain poorly understood. Utilizing integrated PET/MR for its precise spatial correlation, this study investigated the temporal relationship between gray matter (GM) atrophy and reduced FDG SUVR (RFS) across IPD stages to provide insights for early diagnosis. Methods This prospective study recruited 90 IPD patients stratified by Hoehn-Yahr (H-Y) stage into mild, moderate, and severe groups, alongside 30 age-matched healthy controls (HC). All participants underwent integrated 18F-FDG PET/MR imaging. SPM was used to extract the GM volume (VGM) and standardized uptake value ratio for each brain region. Group differences were analyzed with one-way ANOVA and Bonferroni tests. Spearman correlation analysis was utilized to evaluate the associations of both VGM and metabolic changes with H-Y staging. Individual Z-scores for VGM and metabolic alterations were calculated, and their relationship was examined using Spearman/Pearson correlation, followed by paired t-tests to compare their differences. Result With disease progression, GM atrophy and RFS in IPD patients gradually extend from focal to widespread patterns. A characteristic pattern of cerebral hypermetabolism was observed in IPD. H-Y stage demonstrated a significant inverse correlation with the extent of both brain GM atrophy (affecting 82 out of 90 regions) and RFS (affecting 20 regions). Conversely, it was positively correlated with hypermetabolism in regions including the sensorimotor cortex, amygdala, and globus pallidus. Moderate correlations between atrophy and RFS were confined to the left inferior parietal lobule (r = 0.619, p < 0.001) and superior temporal gyrus of the temporal pole (r = 0.612, p < 0.001) only in severe group. In early stages, the number of regions where RFS predominated over atrophy (57 regions) substantially exceeded those where atrophy was more severe (1 region). In late stages, the number of regions with more pronounced atrophy than RFS (25 regions) surpassed that of regions where RFS was dominant (12 regions). Conclusion Widespread RFS predominates during early stages, whereas structural atrophy gradually becomes the dominant imaging feature as the disease advances. These alterations are significantly correlated with disease severity, underscoring the potential of multimodal imaging biomarkers for the early diagnosis of IPD and monitor its progression.
Hypometabolism is a sensitive and early marker of AD-related neurodegeneration, preceding MRI-detectable GM atrophy and more closely reflecting underlying tau pathology across disease stages.
Orfeas Vourkas, Linda Zhang, Andrés Jiménez-Pérez et al.· European Journal of Nuclear...· 0 citations
Multimodal PET imaging reveals dynamic interactions between cerebral glucose metabolism and dopaminergic degeneration in Parkinson’s disease, highlighting cerebellar-pontine hypermetabolism as a compensatory response to nigrostriatal degeneration.
Shuang Li, Wei-Zhao Lu, Shao-Zhen Yan et al.· Cerebellum· 0 citations
Deep learning–based amyloid PET segmentation enables accurate MRI-free quantification of gray and white matter SUVRs and simplifies clinical workflow while maintaining diagnostic performance comparable to MRI-based methods for AD diagnosis.
Seung-Ho Shin, Yong-Jun Mo, Hee Sung Hwang et al.· Journal of Alzheimer's Disea...· 0 citations
Automated MRI volumetry may support the quantitative assessment of neurodegeneration in clinically defined AD and MCI, although these findings require external validation in larger, longitudinal, biomarker-characterized cohorts.
A. Alagoz, Serap Ozturk, S. D. Bunul et al.· Diagnostics· 0 citations
White matter microstructural disruption is a dominant imaging signature of CBS and is more closely linked to gray matter volume loss than to measurable uptake on tau PET, while dMRI, particularly MD and ICVF, may provide greatest sensitivity for detecting disease-related changes in CBS.
Yu-Qi Tian, Ryota Satoh, V. Lowe et al.· medRxiv· 0 citations
It is suggested that MRI-derived measures of cortical thickness, tissue volumes, BPV, and BPF provide useful structural biomarkers of AD and emphasize the importance of considering voxel geometry and segmentation methodology when evaluating neuroimaging biomarkers.